Akebia Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 4, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 4:30 p.m. ET. An audio replay of the presentation will be available through the Investors section of Akebia's website at https://ir.akebia.com for approximately 30 days following the conference. About Akebia Therapeutics Akebia Therapeutics Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-40th-annual-jp-morgan-healthcare-conference-301452956.html SOURCE Akebia Therapeutics |
||
Company Codes: NASDAQ-NMS:AKBA |